Stage 5: GFR <15

Expanding and Promoting Alternative Care and Knowledge in Decision-Making: The ExPAND Study

Protocol Name: Expanding and Promoting Alternative Care and Knowledge in Decision-Making: The ExPAND Study (Improving Shared Decision-Making and Access to Non-Dialytic Treatment for People with Kidney Disease) Sponsor: PCORI / GWU Indication: Late Stage CKD GFR: <20 DETAILS >

Expanding and Promoting Alternative Care and Knowledge in Decision-Making: The ExPAND Study Read More »

Observational Study Protocol – Fabry Disease Registry

Protocol Name: Observational Study Protocol – Fabry Disease Registry Sponsor: Sanofi-Aventis Indication: Fabry Disease Principal Investigator: Ankit Mehta, MD Location: Dallas Transplant Institute, 3604 Live Oak Street, Suite 100, Dallas, TX 75204 DETAILS >

Observational Study Protocol – Fabry Disease Registry Read More »